Evidence map›Paper›PMID 26193637›Full record

ArticleThe Journal of clinical investigation2015

Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma.

Emily Z Keung, Kadir C Akdemir, Ghadah A Al Sannaa, Jeannine Garnett, Dina Lev, Keila E Torres, Alexander J Lazar, Kunal Rai, Lynda Chin

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.Laboratory investigation; a journal of technical methods and pathology · 2022
    Article
  12. Review
  13. Epigenetics of Cutaneous Sarcoma.International journal of molecular sciences · 2021
    Review
  14. Recent Advancement in Atypical Lipomatous Tumor Research.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Emily Z Keung
Kadir C Akdemir
Ghadah A Al Sannaa
Jeannine Garnett
Dina Lev
Keila E Torres
Alexander J Lazar
Kunal Rai
Lynda Chin
The University of Texas MD Anderson Cancer Center · USGenomic (Brazil) · BRSociety of Surgical Oncology · USSheba Medical Center · IL

Funding

TRAINING OF ACADEMIC SURGICAL ONCOLOGISTST32CA009599 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Ashley M Holder, Jennifer A. Wargo · 1988 to 2026
$13.2M
Axl receptor signaling in MPNST; potential node for therapyK08CA160443 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI TORRES, KEILA ENITT · 2012 to 2016
$853k
Epigenetics of Melanoma MetastasisR00CA160578 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RAI, KUNAL · 2015 to 2017
$747k
Epigenetics of Melanoma MetastasisK99CA160578 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RAI, KUNAL · 2011 to 2012
$284k
NCI NIH HHS 1K99CA160578-01NCI NIH HHS 5K08CA160443-03NCI NIH HHS K08 CA160443NCI NIH HHS K99 CA160578NCI NIH HHS R00 CA160578NCI NIH HHS T32 CA009599NCI NIH HHS T32CA009599
6 · The paper itself

Abstract

Liposarcoma (LPS) can be divided into 4 different subtypes, of which well-differentiated LPS (WDLPS) and dedifferentiated LPS (DDLPS) are the most common. WDLPS is typically low grade, whereas DDLPS is high grade, aggressive, and carries a worse prognosis. WDLPS and DDLPS frequently co-occur in patients. However, it is not clear whether DDLPS arises independently from WDLPS, or whether epigenomic alterations underly the histopathological differences of these subtypes. Here, we profiled 9 epigenetic marks in tumor samples from 151 patients with LPS and showed elevated trimethylation of histone H3 at Lys9 (H3K9me3) levels in DDLPS tumors. Integrated ChIP-seq and gene expression analyses of patient-derived cell lines revealed that H3K9me3 mediates differential regulation of genes involved in cellular differentiation and migration. Among these, Kruppel-like factor 6 (KLF6) was reduced in DDLPS, with increased H3K9me3 at associated regulatory regions. Pharmacologic inhibition of H3K9me3 with chaetocin decreased DDLPS proliferation and increased expression of the adipogenesis-associated factors PPARγ, CEBPα, and CEBPβ, suggesting that increased H3K9me3 may mediate DDLPS-associated aggressiveness and dedifferentiation properties. KLF6 overexpression partially phenocopied chaetocin treatment in DDLPS cells and induced phenotypic changes that were consistent with adipocytic differentiation, suggesting that the effects of increased H3K9me3 may be mediated through KLF6. In conclusion, we provide evidence of an epigenetic basis for the transition between WDLPS and DDLPS.

Indexed as

Cell DedifferentiationEpigenesis, GeneticGene Expression Regulation, NeoplasticAdipocytesBiomarkers, TumorCell Line, TumorFemaleHistonesHumansKruppel-Like Factor 6Kruppel-Like Transcription FactorsLiposarcomaMalePiperazinesProto-Oncogene ProteinsBiomarkers, TumorchaetocinHistonesKLF6 protein, humanKruppel-Like Factor 6Kruppel-Like Transcription FactorsPiperazinesProto-Oncogene Proteins

Identifiers

PMID26193637
PMCPMC4563740
OpenAlexW2112949030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.